| Name | Title | Contact Details |
|---|
Aurora Spine Corporation focuses on the development and distribution of spinal implant products for relieving back pain, and preserving spinal bone structure and anatomy in the United States. The company intends to provide interspinous process lumbar fusion devices for patients suffering from degenerative disc disease whose pain has not been eliminated by non-surgical treatment methods; polyether ether ketone interbody cages for use in spinal fusion procedures; and cervical and lumbar devices. It also plans to develop installation tools for surgeons. The company was incorporated in 2013 and is headquartered in Toronto, Canada.
Heartland Health Care Ctr is a Kalamazoo, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Newcastle Place is a Mequon, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
eCare21`s mHealth application collects, compares and analyzes real-time information about users health and wellness. eCare21 integrates the efforts of families, doctors, nurses, volunteers, businesses – and seniors themselves to build a care model suitable for the 21st century. eCare21 seamlessly integrates with wearable and medical devices, Electronic Health Records and healthcare management systems, providing a single point continuous care solution for seniors.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT™ Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. The Company's LUMA imaging technology has received FDA approval for an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available in the market today.